Obesity Surgery

, Volume 29, Issue 2, pp 506–510 | Cite as

Patients with Schizophrenia Do Not Demonstrate Worse Outcome After Sleeve Gastrectomy: a Short-Term Cohort Study

  • Rami ArchidEmail author
  • Nicole Archid
  • Tobias Meile
  • Jonas Hoffmann
  • Julia Hilbert
  • Daniel Wulff
  • Martin Teufel
  • Michaela Muthig
  • Markus Quante
  • Alfred Königsrainer
  • Jessica Lange
Original Contributions



The aim of this study was to compare surgical and psychiatric outcome and weight loss in schizophrenia patients with mentally healthy patients after sleeve gastrectomy.

Materials and Methods

A cohort study design was selected, comprising patients with schizophrenia with mentally healthy patients who underwent sleeve gastrectomy and were adherent to a follow-up at least 12 months after surgery.


Seven schizophrenia (5 male, 2 female) and 59 (12 male, 47 female) mentally healthy patients were included in this study. A laparoscopic sleeve gastrectomy was performed safely in all 66 patients. The calculated excess weight loss (%EWL) showed no significant differences in both groups and reached 51.68 ± 15.84% for schizophrenia group and 60.68 ± 19.95% for mentally healthy group at 24-month follow-up (p = 0.33). The decrease in the HbA1c levels within 2 years after sleeve gastrectomy was similar in both groups (p = 0.79, 0.88, 0.82, 0.73 for surgery time, time of 6-, 12-, and 24-month follow-up respectively). The psychiatric status of the patients of the schizophrenia group was stable in all cases and no exacerbation of psychiatric symptoms was observed during time of follow-up. Furthermore, an overall significant improvement of the self-estimated mood and satisfaction was observed in both groups (Manova: f = 1.26, p < 0.0001).


The results 2 years after sleeve gastrectomy in stable patients with schizophrenia and after an adequate psychological evaluation were encouraging and comparable to the outcome in mentally healthy patients.


Bariatric surgery Obesity Schizophrenia Mental illness Sleeve gastrectomy 


Compliance with Ethical Standards

This study was approved by the local ethic committee at the University Hospital of Tübingen, Germany.

Conflict of Interest

The authors declare that they have no conflict of interest.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.


  1. 1.
    Daumit GL, Clark JM, Steinwachs DM, et al. Prevalence and correlates of obesity in a community sample of individuals with severe and persistent mental illness. J Nerv Ment Dis. 2003;191(12):799–805.Google Scholar
  2. 2.
    Colton CW, Manderscheid RW. Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Prev Chronic Dis. 2006;3(2):A42.Google Scholar
  3. 3.
    Newcomer JW, Hennekens CH. Severe mental illness and risk of cardiovascular disease. JAMA. 2007;298(15):1794–6.Google Scholar
  4. 4.
    Yu W, De Hert M, Moons T, et al. CNR1 gene and risk of the metabolic syndrome in patients with schizophrenia. J Clin Psychopharmacol. 2013;33(2):186–92.Google Scholar
  5. 5.
    Allison DB, Newcomer JW, Dunn AL, et al. Obesity among those with mental disorders: a National Institute of Mental Health meeting report. Am J Prev Med. 2009;36(4):341–50.Google Scholar
  6. 6.
    Nemeroff CB. Dosing the antipsychotic medication olanzapine. J Clin Psychiatry. 1997;58(Suppl 10):45–9.Google Scholar
  7. 7.
    Thakore JH, Mann JN, Vlahos I, et al. Increased visceral fat distribution in drug-naive and drug-free patients with schizophrenia. Int J Obes Relat Metab Disord. 2002;26(1):137–41.Google Scholar
  8. 8.
    Adams TD, Arterburn DE, Nathan DM, et al. Clinical outcomes of metabolic surgery: microvascular and macrovascular complications. Diabetes Care. 2016;39(6):912–23.Google Scholar
  9. 9.
    Sjostrom L, Peltonen M, Jacobson P, et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA. 2014;311(22):2297–304.Google Scholar
  10. 10.
    Adams TD, Mehta TS, Davidson LE, et al. Cause-specific mortality associated with bariatric surgery: a review. Curr Atheroscler Rep. 2015;17(12):74.Google Scholar
  11. 11.
    Bauchowitz AU, Gonder-Frederick LA, Olbrisch ME, et al. Psychosocial evaluation of bariatric surgery candidates: a survey of present practices. Psychosom Med. 2005;67(5):825–32.Google Scholar
  12. 12.
    Kalarchian MA, Marcus MD, Levine MD, et al. Relationship of psychiatric disorders to 6-month outcomes after gastric bypass. Surg Obes Relat Dis. 2008;4(4):544–9.Google Scholar
  13. 13.
    Powers PS, Rosemurgy A, Boyd F, et al. Outcome of gastric restriction procedures: weight, psychiatric diagnoses, and satisfaction. Obes Surg. 1997;7(6):471–7.Google Scholar
  14. 14.
    Semanscin-Doerr DA, Windover A, Ashton K, et al. Mood disorders in laparoscopic sleeve gastrectomy patients: does it affect early weight loss? Surg Obes Relat Dis. 2010;6(2):191–6.Google Scholar
  15. 15.
    Dubovsky SL, Haddenhorst A, Murphy J, et al. A preliminary study of the relationship between preoperative depression and weight loss following surgery for morbid obesity. Int J Psychiatry Med. 1985;15(2):185–96.Google Scholar
  16. 16.
    Hamoui N, Kingsbury S, Anthone GJ, et al. Surgical treatment of morbid obesity in schizophrenic patients. Obes Surg. 2004;14(3):349–52.Google Scholar
  17. 17.
    Steinmann WC, Suttmoeller K, Chitima-Matsiga R, et al. Bariatric surgery: 1-year weight loss outcomes in patients with bipolar and other psychiatric disorders. Obes Surg. 2011;21(9):1323–9.Google Scholar
  18. 18.
    Nasrallah HA, Meyer JM, Goff DC, et al. Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline. Schizophr Res. 2006;86(1–3):15–22.Google Scholar
  19. 19.
    McKibbin CL, Patterson TL, Norman G, et al. A lifestyle intervention for older schizophrenia patients with diabetes mellitus: a randomized controlled trial. Schizophr Res. 2006;86(1–3):36–44.Google Scholar
  20. 20.
    Fuchs HF, Laughter V, Harnsberger CR, et al. Patients with psychiatric comorbidity can safely undergo bariatric surgery with equivalent success. Surg Endosc. 2016;30(1):251–8.Google Scholar
  21. 21.
    Ahmed AT, Warton EM, Schaefer CA, et al. The effect of bariatric surgery on psychiatric course among patients with bipolar disorder. Bipolar Disord. 2013;15(7):753–63.Google Scholar
  22. 22.
    Lawlor BA, Rand CS. Schizophrenia and gastric surgery for obesity. Am J Psychiatry. 1986;143(10):1321.Google Scholar
  23. 23.
    Shelby SR, Labott S, Stout RA. Bariatric surgery: a viable treatment option for patients with severe mental illness. Surg Obes Relat Dis. 2015;11(6):1342–8.Google Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Rami Archid
    • 1
    Email author
  • Nicole Archid
    • 1
  • Tobias Meile
    • 2
  • Jonas Hoffmann
    • 1
  • Julia Hilbert
    • 1
  • Daniel Wulff
    • 1
  • Martin Teufel
    • 3
    • 4
  • Michaela Muthig
    • 3
  • Markus Quante
    • 1
  • Alfred Königsrainer
    • 1
  • Jessica Lange
    • 1
  1. 1.Department of General, Visceral and Transplant SurgeryEberhard-Karls-University Hospital TuebingenTübingenGermany
  2. 2.Department of General, Visceral and Transplant SurgeryBad Cannstatt HospitalStuttgartGermany
  3. 3.Department of Psychosomatic Medicine and PsychotherapyEberhard-Karls-University Hospital TuebingenTübingenGermany
  4. 4.Clinic for Psychosomatic Medicine and PsychotherapyUniversity of Duisburg-EssenEssenGermany

Personalised recommendations